Amgen-AstraZeneca Team ahead Zacks.com The candidates to be developed under this agreement include brodalumab ( psoriasis - phase 3 to commence, psoriatic arthritis and asthma - state of matter II), AMG 139 (Crohn's disease - phase Ib), AMG 181 (ulcerative inflammation - phase Ia and Crohn's disease ... and more » Link To Article
No comments:
Post a Comment